Cardium Announces Patent Award For Rights To Cardiovascular Gene Therapy For The Treatment Of Heart Disease

Resolves Long-standing Competition with Boston Scientific Corporation Over Rights to Cardiovascular Gene Therapy in the U.S. and Europe

Updated Cardium Therapeutics (NYSE MKT: CXM) Investor Presentation including the acquisition of To Go Brands that was announced on October 1, 2012.

The link provided is for SlideShare.  The presentation can also be found on the Cardium Therapeutics website at:  http://phx.corporate-ir.net/phoenix.zhtml?c=77949&p=irol-presentations

New York, New York - September 13, 2012 (Investorideas.com Newswire) - Investorideas.com, a leader in sector stock research including biotech stocks, issues a trading alert for stem cell stock Neuralstem, Inc. (NYSE MKT : CUR) , trading at $1.42, up $0.42 or 42.00% as of 11:41AM EDT on over 4 Million shares. The stock had a morning high of $1.46.

Cardium Therapeutics (NYSE MKT: CXM) today announced that its professional-use Excellagen® (formulated collagen gel 2.6%) wound care product was selected as one of the top ten podiatry innovations in 2012 by the publication Podiatry Today. The Company also announced that it will be introducing Excellagen at the American Podiatric Medical Association (APMA) National Meeting (Booth 1910) being held August 16 – 19, 2012 in Washington, DC.

Christopher J. Reinhard, Chairman & CEO presented at the Marcum MicroCap Conference on June 20, 2012 at at the Roosevelt Hotel in New York City. In the presentation, Mr. Reinhard details Cardium products, including Generx as a product candidate for advanced coronary artery disease, Excellagen for wound care management and the company’s line of MedPodium neutraceuticals,metabolics and aesthetics.

Learning Tree International Inc. (NASDAQ:LTRE) announced that Dr. David C. Collins has replaced Nick Schacht as its Chief Executive Officer. Dr. Collins also has been appointed Chairman of the Board, and Eric Garen has filled the position of Vice Chairman which Dr. Collins vacated.